The independence of signaling pathways mediating increased expression of plasminogen activator inhibitor type 1 in HepG2 cells exposed to free fatty acids or triglycerides

International Journal of Experimental Diabetes Research

Volumn 3, Issue 2, 2002, Pages 109-118

  Chen, Yabing ^a   Schneider, David J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Diabetes; Free fatty acids; Plasminogen activator inhibitor type 1; Protein kinase C; Triglycerides

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; BISINDOLYLMALEIMIDE; FATTY ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C INHIBITOR; TRIACYLGLYCEROL;

CELL STRAIN HEPG2; CONTROLLED STUDY; EXPOSURE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

5' UNTRANSLATED REGIONS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TRIGLYCERIDES; TUMOR CELLS, CULTURED;

EID: 0036248575     PISSN: 15604284     EISSN: None     Source Type: Journal    
DOI: 10.1080/15604280214488     Document Type: Review

References (40)

1. Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells
2. Effects of gemfibrozil on lipids and haemostasis after myocardial infarction
3. Studies on the Mechanism of Fibrate-Inhibited Expression of Plasminogen Activator Inhibitor-1 in Cultured Hepatocytes From Cynomolgus Monkey
4. Role of c-Jun and proximal phorbol 12-myristate-13-acetate-(PMA)-responsive elements in the regulation of basal and PMA-stimulated plasminogen-activator inhibitor-1 gene expression in HepG2
5. Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells
6. Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin. A potential link between lipid lowering and fibrinolysis
7. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects
8. Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene
9. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells
10. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element
11. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
12. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia
13. Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C
14. Short-term infusions of insulin, triacylglycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in man
15. Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: A role for plasminogen activator inhibitor?
16. Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-beta signaling
17. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherosthrombosis
18. Relationships Between Plasma Insulin Triglyceride, Body Mass Index and Plasminogen Activator Inhibitor 1
19. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins
20. Increased Plasminogen Activator Inhibitor Activity in Survivors of Myoardial Infarction Is Associated with Metabolic Risk Factors of Atherosclerosis
21. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human Possible involvement of proto-oncogenes c-jun and c-fos
22. Tumor necrosis factor-alpha regulates plasminogen activator inhibitor-1 in rat testicular peritubular cells
23. Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells
24. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
25. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations
26. Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells
27. Association of TGF-beta signaling in angiotensin II-induced PAI-1 mRNA upregulation in mesangial cells: Role of PKC
28. Hypertriglyceridemia and regulation of fibrinolytic activity
29. Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells
30. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: Involvement of the VLDL receptor
31. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo
32. Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells
33. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: Implications for vascular disease in hyperinsulinemic states
34. Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids
35. Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL
36. Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox
37. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein
38. No evidence for short-term regulation of plasminogen activator inhibitor activity by insulin in man
39. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the CasTemoins de I'nfarctus du Mycocarde
40. Endothelin-1 enhances plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-dependent pathway